Data / Form D filings / Noveome Biotherapeutics, Inc.
Noveome Biotherapeutics, Inc.: Form D filings
Noveome Biotherapeutics, Inc., a biotechnology company in Pittsburgh, PA, filed 9 Form D notices with the SEC between 2012 and 2026. The latest, on August 27, 2026, reports $6.8 million sold of a $15 million offering to 6 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 620 ALPHA DRIVE SUITE 2, Pittsburgh, PA, 15238
- Phone
- (412) 799-6157
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1478304
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Aug 27, 2026 | New notice | $15,000,000 | $6,750,503 | $8,249,497 | 6 | Aug 12, 2026 | sec.gov |
| Aug 8, 2024 | Amendment | $51,270,077 | $36,184,531 | $15,085,546 | 66 | Aug 2, 2023 | sec.gov |
| Aug 17, 2023 | New notice | $40,190,480 | $20,690,480 | $19,500,000 | 59 | Aug 2, 2023 | sec.gov |
| Oct 2, 2020 | New notice | $15,000,000 | $870,000 | $14,130,000 | 7 | Sep 24, 2020 | sec.gov |
| Apr 22, 2019 | Amendment | $15,000,000 | $15,000,000 | 39 | Jan 12, 2018 | sec.gov | |
| Jan 24, 2018 | New notice | $15,000,000 | $2,368,922 | $12,631,078 | 10 | Jan 12, 2018 | sec.gov |
| Apr 14, 2016 | Amendment | $2,500,000 | $2,158,479 | $341,521 | 39 | Dec 31, 2015 | sec.gov |
| Jan 13, 2016 | New notice | $2,500,000 | $1,710,796 | $789,204 | 33 | Dec 31, 2015 | sec.gov |
| Jul 12, 2012 | New notice | $570,746 | $570,746 | 15 | Jun 30, 2012 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Patrick Welch | Executive Officer, Director | |
| Robert Langer | Director | |
| Ronald Poropatich | Director | |
| Eric Keller | Executive Officer, Director | |
| Houman Hemmati | Director | |
| Craig Nemiroff | Director | |
| Michael Kaufman | Director | |
| Karin Potoka | Executive Officer | |
| Larry Brown | Executive Officer |
Other biotechnology companies in Pennsylvania that filed recently
- BioLattice Ophthalmics, Inc, $1.8 million · Oct 28, 2026
- Myris Therapeutics, Inc. $500,000 · Oct 14, 2026
- Praeventix, Inc. $5.6 million · Sep 10, 2026
- Plowshare Therapies LLC $6.7 million · Aug 31, 2026
- AlloTRx Bio Inc. $500,000 · Aug 24, 2026
- Aposture Surgical Corp $87,000 · Aug 13, 2026
Every Form D from the week of Aug 24, 2026 · All recent filings in Pennsylvania · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Noveome Biotherapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.